Otto Pulkkinen
- TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicity (2024)
- Genes and Immunity
- Target-specific compound selectivity for multi-target drug discovery and repurposing (2022)
- Frontiers in Pharmacology
- Multiobjective optimization identifies cancer-selective combination therapies (2020)
- PLoS Computational Biology